Nanogels are three-dimensional nanoscale networks formed by physically or chemically crosslinking polymers. Nanogels have been explored as drug delivery systems due to their advantageous properties, such as biocompatibility, high stability, tunable particle size, drug loading capacity, and possible modification of the surface for active targeting by attaching ligands that recognize cognate receptors on the target cells or tissues. Nanogels can be designed to be stimulus responsive, and react to internal or external stimuli such as pH, temperature, light, redox, thus resulting in the controlled release of loaded drug. This "smart" targeting ability prevents drug accumulation in non-target tissues and minimizes the side effects of the drug. This review aims to provide an introduction to nanogels, their preparation methods, and to discuss the design of various stimulus-responsive nanogels that are able to provide controlled drug release in response to particular stimuli.

Cardiovascular diseases are the number one cause of heart failure and death in the world, and the transplantation of the heart is an effective and viable choice for treatment despite presenting many disadvantages (most notably, transplant heart availability). To overcome this problem, cardiac tissue engineering is considered a promising approach by using implantable artificial blood vessels, injectable gels, and cardiac patches (to name a few) made from biodegradable polymers. Biodegradable polymers are classified into two main categories: natural and synthetic polymers. Natural biodegradable polymers have some distinct advantages such as biodegradability, abundant availability, and renewability but have some significant drawbacks such as rapid degradation, insufficient electrical conductivity, immunological reaction, and poor mechanical properties for cardiac tissue engineering. Synthetic biodegradable polymers have some advantages such as strong mechanical properties, controlled structure, great processing flexibility, and usually no immunological concerns; however, they have some drawbacks such as a lack of cell attachment and possible low biocompatibility. Some applications have combined the best of both and exciting new natural/ synthetic composites have been utilized. Recently, the use of nanostructured polymers and polymer nanocomposites has revolutionized the field of cardiac tissue engineering due to their enhanced mechanical, electrical, and surface properties promoting tissue growth. In this review, recent research on the use of biodegradable natural/synthetic nanocomposite polymers in cardiac tissue engineering is presented with forward looking thoughts provided for what is needed for the field to mature.

Smart polymers with extraordinary characteristics are studied in drug-delivery applications. In the current study, temperature-responsive hybrid core−shell nanoparticles were synthesized by precipitation polymerization of N-isopropylacrylamide and vinyl-modified silica nanoparticles. These temperature-responsive hybrid core−shells were prepared with different cross-linking densities by using 2, 4, and 8 mol % of N,N-methylene bisacrylamide (MBA). Hydrolysis of the silica cores of the hybrid core−shells resulted in hollow poly(Nisopropylacrylamide) (PNIPAM) nanogels. Functionalization of silica nanoparticles with vinylcontaining silane modifier of 3-(trimethoxysilyl) propyl methacrylate (MPS) in two different contents was proven by Fourier transform infrared spectroscopy. Preparation of the hybrid PNIPAM nanogels and etching of the silica cores were studied using thermogravimetric analysis and also electron microscopy imaging. Sensitivity of the PNIPAM nanogel samples to temperature was studied using ultraviolet−visible (UV−vis) spectroscopy. In addition, dynamic light scattering was used for investigation of the squeezing and expansion of the hybrid and hollow samples against variation of temperature. The UV−vis spectroscopy results display higher absorption intensities in higher contents of MPS modifier and MBA cross-linker. The swelling content of the nanogels with hollow cavities was higher than that of the hybrid samples. The hybrid nanogels with 2 and 8 wt % silica content and different cross-linking densities and also their hollow nanoparticles were used for loading and release of doxorubicin (DOX). The release characteristics of the DOX-loaded nanogels were studied at different temperatures using UV−vis spectroscopy. The DOX release was higher at temperatures lower than the gel collapse temperature of the PNIPAM network. Although the nanogels with hollow cavities displayed higher loading capacities, the release percentage was higher for the hybrid PNIPAM nanogels, which was confirmed by the experimental release profiles and mathematical models. The most appropriate fitting of the DOX release data from the PNIPAM nanogel samples was observed for the Korsmeyer−Peppas model. Cytotoxicity studies on HeLa cell line showed that drug-loaded hollow samples showed higher toxicity due to loading of a higher amount of DOX.

No abstract

No abstract

No abstract

Conventional drug delivery systems are challenged by concerns related to systemic toxicity, repetitive doses, drug concentrations fluctuation, and adverse effects. Various drug delivery systems are developed to overcome these limitations. Nanomaterials are employed in a variety of biomedical applications such as therapeutics delivery, cancer therapy, and tissue engineering. Physiochemical nanoparticle assembly techniques involve the application of solvents and potentially harmful chemicals, commonly at high temperatures. Genetically engineered organisms have the potential to be used as promising candidates for greener, efficient, and more adaptable platforms for the synthesis and assembly of nanomaterials. Genetically engineered carriers are precisely designed and constructed in shape and size, enabling precise control over drug attachment sites. The high accuracy of these novel advanced materials, biocompatibility, and stimuli‐responsiveness, elucidate their emerging application in controlled drug delivery. The current article represents the research progress in developing various genetically engineered carriers. Organic‐based nanoparticles including cellulose, collagen, silk‐like polymers, elastin‐like protein, silk‐elastin‐like protein, and inorganic‐based nanoparticles are discussed in detail. Afterward, viral‐based carriers are classified, and their potential for targeted therapeutics delivery is highlighted. Finally, the challenges and prospects of these delivery systems are concluded.

No abstract